# ROADSTER 3 Extended Follow-up Sub-Study

> **NCT06470815** · — · TERMINATED · sponsor: **Silk Road Medical** · enrollment: 197 (actual)

## Conditions studied

- Carotid Artery Diseases

## Interventions

- **PROCEDURE:** Transcarotid Artery Revascularization (TCAR)

## Key facts

- **NCT ID:** NCT06470815
- **Lead sponsor:** Silk Road Medical
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2024-07-31
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 197 (ACTUAL)
- **Why stopped:** The decision to close the study is not related to any safety concerns or newly identified risks to patients.
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06470815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06470815, "ROADSTER 3 Extended Follow-up Sub-Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06470815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*